Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights
description
Transcript of Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights
![Page 1: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/1.jpg)
Research Advances in Cystic Fibrosis
Expert Interpretations and Clinical Insights
![Page 2: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/2.jpg)
Data on Nebulized Levofloxacin and Guidance on Psychosocial
Support
![Page 3: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/3.jpg)
Nebulized Levofloxacin For Chronic P aeruginosa infection
![Page 4: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/4.jpg)
Results
![Page 5: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/5.jpg)
Results (cont)
![Page 6: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/6.jpg)
Depression and Anxiety in Patients With CF
![Page 7: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/7.jpg)
Best Practice Guidelines: Psychosocial Support
![Page 8: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/8.jpg)
Best Practice Guidelines: Psychosocial Support (cont)
![Page 9: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/9.jpg)
Key Transition Points
![Page 10: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/10.jpg)
An Update on Ivacaftor and the Evolving Role of MRI
![Page 11: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/11.jpg)
Background
![Page 12: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/12.jpg)
KONDUCT Study
![Page 13: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/13.jpg)
KONDUCT Study (cont)
![Page 14: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/14.jpg)
Additional Findings
![Page 15: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/15.jpg)
Additional Findings (cont)
![Page 16: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/16.jpg)
Investigators’ Conclusion
![Page 17: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/17.jpg)
MRI Detection of Lung Ventilation Defects in CF
![Page 18: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/18.jpg)
Additional Results
![Page 19: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/19.jpg)
MRI Assessment of Response to Therapy
![Page 20: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/20.jpg)
Additional Findings
![Page 21: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/21.jpg)
Take-home Points
![Page 22: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/22.jpg)
MRI Evaluation of Pulmonary Blood Flow
![Page 23: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/23.jpg)
Take-home Point
![Page 24: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/24.jpg)
Recommendations For Exercise and For CFTR Modulator Therapy
![Page 25: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/25.jpg)
The Importance of Exercise in CF
![Page 26: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/26.jpg)
Results
![Page 27: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/27.jpg)
Best Practices: CFTR Modulator Therapy
![Page 28: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/28.jpg)
Best Practices: CFTR Modulator Therapy (cont)
![Page 29: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/29.jpg)
Best Practices: CFTR Modulator Therapy (cont)
![Page 30: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/30.jpg)
The Ronan et al Study
![Page 31: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/31.jpg)
Does Ivacaftor Improve Lung Function By Altering Airway
Microbiology?
![Page 32: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/32.jpg)
Effect of Ivacaftor on Mucociliary Clearance
![Page 33: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/33.jpg)
KONNECTION Study
![Page 34: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/34.jpg)
Results
![Page 35: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/35.jpg)
Take-home Points
![Page 36: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/36.jpg)
New Findings on Inhaled Antibiotic Therapies
![Page 37: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/37.jpg)
Once-daily Inhaled Liposomal Amikacin
![Page 38: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/38.jpg)
Study Design
![Page 39: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/39.jpg)
Highlights of Efficacy Results
![Page 40: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/40.jpg)
Highlights of Efficacy Results (cont)
![Page 41: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/41.jpg)
Highlights of Safety Results
![Page 42: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/42.jpg)
Take-home Point
![Page 43: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/43.jpg)
Incorporating a Third Inhaled Antipseudomonal Antibiotic Class
![Page 44: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/44.jpg)
Highlights of Results
![Page 45: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/45.jpg)
Highlights of Results (cont)
![Page 46: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/46.jpg)
Abbreviations
![Page 47: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/47.jpg)
References
![Page 48: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/48.jpg)
References (cont)
![Page 49: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.fdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/49.jpg)
References (cont)